A disease with a thousand faces. One day you don't know how you'll wake up.
For decades, a diagnosis of multiple sclerosis carried the weight of a foregone conclusion—the wheelchair, the slow erasure of independence, the life interrupted. Today, that narrative is being rewritten. In Spain, where some sixty thousand people live with the condition, three decades of medical progress have transformed a disease once met with near-helplessness into one managed with precision and personalized care. The story of this shift is not only one of science, but of what it means to build a life alongside an illness that refuses to stay still.
- A diagnosis that once conjured images of inevitable disability now arrives into a medical landscape where tailored treatments can delay or prevent that outcome entirely.
- The disease is expanding its reach—striking children, adults over sixty-five, and a widening middle range—challenging the assumption that MS belongs only to young women in their prime.
- Invisible symptoms like crushing fatigue, depression, cognitive fog, and chronic pain remain stubbornly difficult to treat, quietly eroding lives in ways no scan can fully capture.
- Patient associations and multidisciplinary care teams are filling the gap between medical treatment and human wholeness, offering psychological, physical, and occupational support.
- The trajectory is cautiously hopeful: more treatments are coming, diagnosis is faster, and people who once feared the worst are instead negotiating a complex but livable future.
Gema Pizana was twenty-seven when her right eye simply stopped working. What followed—tests, uncertainty, and finally a diagnosis of multiple sclerosis—sent her to the internet, where she found only images of wheelchairs and foreclosed lives. She was engaged, newly graduated, standing at the beginning of everything. "You're starting your life and suddenly they tell you this," she recalls. "It's a shock because you don't even know what it is."
The early years felt like mourning. But through the Asociación de Esclerosis Múltiple de Elche y Crevillente, she found a different way of understanding her situation—not as a sentence, but as a condition to be lived with, adapted to, navigated day by uncertain day. Some episodes took her vision. Others stole mobility from one side of her body. Numbness, pain, and unpredictability became the texture of her life. "It's a disease with a thousand faces," she says. More than two decades later, she remains mobile and independent—without the wheelchair she once thought was inevitable.
Her experience reflects a broader transformation in how multiple sclerosis is understood and treated. Spain has between fifty-five and sixty thousand patients, and neurologist Lucienne Costa-Frossad of Hospital Ramón y Cajal notes that the age of diagnosis is widening—ten percent of new cases now occur in children, another ten percent in patients over sixty-five. Thirty years ago, doctors had almost nothing to offer. Today, treatments are numerous, increasingly personalized, and still expanding. "We've gone from having practically no options to having many treatments, and more are coming," Costa-Frossad says.
The myth that MS inevitably leads to a wheelchair is crumbling. María José Marroquí, president of the Elche association, puts it plainly: "Today, thanks to advances, we're taking longer and longer to reach that point—or we don't reach it at all." Still, the hardest symptoms to treat are often the least visible: fatigue, depression, cognitive changes, chronic pain. These don't appear in photographs, but they quietly diminish quality of life in ways mobility aids cannot address. Managing the disease now means attending to the whole person—mind and body, the invisible alongside the visible—with continuous monitoring and sustained care as the true long-term work.
Gema Pizana was twenty-seven when the diagnosis arrived—multiple sclerosis, a word that meant nothing to her then, a word that still means everything now. It started with her right eye. The vision simply went, and she assumed stress, or something manageable, something that would pass. The medical tests that followed chased a dozen possibilities: tumor, other neurological conditions, the usual suspects of uncertainty. When the confirmation came, she did what most people do. She searched the internet. What she found terrified her—images of people in wheelchairs, bodies that no longer moved, lives that seemed to have ended. She was at the threshold of everything: engaged, freshly graduated, beginning her career. "You're starting your life and suddenly they tell you this," she recalls more than two decades later. "It's a shock because you don't even know what it is."
The early years were a kind of grief. Pizana describes it as mourning the life she thought she would have, the person she thought she would be. But the Asociación de Esclerosis Múltiple de Elche y Crevillente—a patient support organization in her city—became her anchor. Through them she learned not to predict the disease's path, not to surrender to the worst-case scenarios that internet searches had planted in her mind. She learned to live with it instead, to adapt as the disease itself adapted, shifting its presentation without warning. Some days brought partial vision loss. Other times her mobility on one side of her body would vanish. There were episodes of numbness, stretches of neurological pain. "It's a disease with a thousand faces," she says. "One day you don't know how you'll wake up or what will happen to you." Yet over more than twenty years, she has managed to build a life around it—personal, professional, functional—without the wheelchair that once seemed inevitable.
Her story sits within a larger medical narrative that has shifted dramatically in recent decades. Spain has between fifty-five thousand and sixty thousand people living with multiple sclerosis, according to neurologist Lucienne Costa-Frossad, who specializes in the disease at Hospital Ramón y Cajal in Madrid. The condition has traditionally struck women and younger populations hardest, but the age profile is widening. Where diagnoses once clustered between twenty and forty, they now spread across thirty to fifty. More striking still: ten percent of new diagnoses now occur in children, and another ten percent in patients over sixty-five. The disease remains the second leading cause of disability among young people, yet the landscape of possibility has transformed entirely.
Thirty years ago, there were almost no treatment options. Doctors could offer little beyond management of symptoms and the grim knowledge that disability was likely inevitable. Today the arsenal is vast and expanding. Costa-Frossad describes the shift in stark terms: "We've gone from having practically no options to having many treatments, and more are coming." The speed of diagnosis has accelerated. The treatments themselves have become personalized—what she calls "a custom suit of medication for each patient." This tailoring is crucial because multiple sclerosis does not present the same way twice, even within the same person. The disease demands precision, and modern medicine is finally equipped to provide it.
María José Marroquí, president of the Elche association, emphasizes one particular myth that has begun to crumble. "People think someone with multiple sclerosis has to end up in a wheelchair," she says. "But today, thanks to advances, we're taking longer and longer to reach that point, or we don't reach it at all." Pizana is living proof. Two decades with the disease and she remains mobile, independent, unconfined. The association itself offers comprehensive support—psychology, physical therapy, occupational therapy, speech therapy, exercise programs—recognizing that the disease touches every dimension of a person's life.
Yet significant challenges remain. The symptoms that specialists struggle most to control are often invisible: fatigue that can be disabling, depression, anxiety, cognitive changes, chronic pain, sleep disturbances. These are not the dramatic symptoms that appear in medical textbooks or internet searches. They don't show in a photograph. But they erode quality of life in ways that mobility aids cannot measure. The medical community now understands that managing multiple sclerosis means attending to the whole person—the mind as much as the body, the invisible as much as the visible. Continuous monitoring, mental engagement, sustained medical follow-up: these have become the real work of living with the disease. For Pizana and thousands like her, the prognosis has shifted from terminal decline to something far more complex and, in many ways, far more hopeful.
Citações Notáveis
We've gone from having practically no options to having many treatments, and more are coming.— Lucienne Costa-Frossad, neurologist specializing in multiple sclerosis
People think someone with multiple sclerosis has to end up in a wheelchair. But today, thanks to advances, we're taking longer and longer to reach that point, or we don't reach it at all.— María José Marroquí, president of the Elche Multiple Sclerosis Association
A Conversa do Hearth Outra perspectiva sobre a história
When Gema first searched for information about her diagnosis, she found images of wheelchairs and immobility. What changed between then and now?
The treatments themselves changed. Thirty years ago there were almost no options. Now there are many, and they're personalized to each person's specific disease pattern. But also the conversation changed. People stopped assuming the worst outcome was inevitable.
She's been living with this for over twenty years without needing a wheelchair. Is that common now?
It's becoming more common, yes. The disease still affects people profoundly, but the timeline has stretched. Some people never reach that point of severe mobility loss. The myth that it always ends one way has been broken.
What about the symptoms doctors still can't control well?
Fatigue, depression, cognitive problems, pain—these are the real battles now. They're invisible, which makes them harder to treat and easier for people around the patient to dismiss. But they're what actually determines whether someone can work, think clearly, sleep.
So the medical advances have solved the dramatic problem but revealed the subtle ones?
Exactly. We've bought people time and function. Now we have to figure out how to give them quality within that time. That's a different kind of work.